Label: LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 1/BEIGE- octinoxate and zinc oxide liquid
LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 2/BEIGE- octinoxate and zinc oxide liquid
LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 3/BEIGE- octinoxate and zinc oxide liquid
LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 4/BEIGE- octinoxate and zinc oxide liquid
LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 5/BEIGE- octinoxate and zinc oxide liquid
LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 6/BEIGE- octinoxate and zinc oxide liquid
LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 7/BEIGE- octinoxate and zinc oxide liquid
LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 8/BEIGE- octinoxate and zinc oxide liquid
LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 9/BROWN- octinoxate and zinc oxide liquid
-
Contains inactivated NDC Code(s)
NDC Code(s): 43596-0126-1, 43596-0126-2, 43596-0127-1, 43596-0127-2, view more43596-0128-1, 43596-0128-2, 43596-0129-1, 43596-0129-2, 43596-0130-1, 43596-0130-2, 43596-0131-1, 43596-0131-2, 43596-0132-1, 43596-0132-2, 43596-0133-1, 43596-0133-2, 43596-0134-1, 43596-0134-2 - Packager: Ventura Corporation LTD
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated November 14, 2019
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- ACTIVE INGREDIENT
- Uses
- Warnings
- Directions
- Other information
-
Inactive ingredients
Dimethicone, mica, zea mays (corn) starch, ozokerite, polyethylene, silica dimethyl silylate, peg/ppg-18/18 dimethicone, copernicia cerifera (carnauba) wax, kojic dipalmitate, cetyl peg/ppg-10/1 dimethicone, polyglyceryl-4 isostearate, hexyl laurate, phenoxyethanol, triethoxycaprylylsilane, caprylyl glycol, chlorphenesin, fragrante, glycyrrhiza glabra (licorice) root extract, trimethylsiloxysilicate, dimethylmethoxy chromanyl palmitato, citronellol, butylphenyl methylpropional, hydroxycitronellal, hexyl cinnamal, d-limonene, hydroxyisohexyl 3-cyclohexene carboxaldehyde, alpha-isomethyl ionone.
May Contain: titanium dioxide, iron oxides.
- SPL UNCLASSIFIED SECTION
- PRINCIPAL DISPLAY PANEL - 9 g Case Box - Claire 1/Beige
- PRINCIPAL DISPLAY PANEL - 9 g Case Box - Claire 2/Beige
- PRINCIPAL DISPLAY PANEL - 9 g Case Box - Claire 3/Beige
- PRINCIPAL DISPLAY PANEL - 9 g Case Box - Claire 4/Beige
- PRINCIPAL DISPLAY PANEL - 9 g Case Box - Claire 5/Beige
- PRINCIPAL DISPLAY PANEL - 9 g Case Box - Claire 6/Beige
- PRINCIPAL DISPLAY PANEL - 9 g Case Box - Claire 7/Beige
- PRINCIPAL DISPLAY PANEL - 9 g Case Box - Claire 8/Beige
- PRINCIPAL DISPLAY PANEL - 9 g Case Box - Claire 9/Brown
-
INGREDIENTS AND APPEARANCE
LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 1/BEIGE
octinoxate and zinc oxide liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:43596-0126 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.075 g in 1 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 0.0784 g in 1 g Inactive Ingredients Ingredient Name Strength Dimethicone (UNII: 92RU3N3Y1O) mica (UNII: V8A1AW0880) starch, corn (UNII: O8232NY3SJ) high density polyethylene (UNII: UG00KM4WR7) silica dimethyl silylate (UNII: EU2PSP0G0W) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) carnauba wax (UNII: R12CBM0EIZ) kojic dipalmitate (UNII: 13N249RWTM) polyglyceryl-4 isostearate (UNII: 820DPX33S7) hexyl laurate (UNII: 4CG9F9W01Q) phenoxyethanol (UNII: HIE492ZZ3T) triethoxycaprylylsilane (UNII: LDC331P08E) caprylyl glycol (UNII: 00YIU5438U) chlorphenesin (UNII: I670DAL4SZ) licorice (UNII: 61ZBX54883) dimethylmethoxy chromanyl palmitate (UNII: 5G222ZDK7U) .beta.-citronellol, (R)- (UNII: P01OUT964K) butylphenyl methylpropional (UNII: T7540GJV69) hydroxycitronellal (UNII: 8SQ0VA4YUR) .alpha.-hexylcinnamaldehyde (UNII: 7X6O37OK2I) limonene, (+)- (UNII: GFD7C86Q1W) hydroxyisohexyl 3-cyclohexene carboxaldehyde (UNII: QUE43B9Z2Q) isomethyl-.alpha.-ionone (UNII: 9XP4LC555B) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide red (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:43596-0126-2 1 in 1 BOX 09/26/2018 1 NDC:43596-0126-1 9 g in 1 CONTAINER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 09/26/2018 LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 2/BEIGE
octinoxate and zinc oxide liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:43596-0127 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.075 g in 1 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 0.0784 g in 1 g Inactive Ingredients Ingredient Name Strength Dimethicone (UNII: 92RU3N3Y1O) mica (UNII: V8A1AW0880) starch, corn (UNII: O8232NY3SJ) high density polyethylene (UNII: UG00KM4WR7) silica dimethyl silylate (UNII: EU2PSP0G0W) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) carnauba wax (UNII: R12CBM0EIZ) kojic dipalmitate (UNII: 13N249RWTM) polyglyceryl-4 isostearate (UNII: 820DPX33S7) hexyl laurate (UNII: 4CG9F9W01Q) phenoxyethanol (UNII: HIE492ZZ3T) triethoxycaprylylsilane (UNII: LDC331P08E) caprylyl glycol (UNII: 00YIU5438U) chlorphenesin (UNII: I670DAL4SZ) licorice (UNII: 61ZBX54883) dimethylmethoxy chromanyl palmitate (UNII: 5G222ZDK7U) .beta.-citronellol, (R)- (UNII: P01OUT964K) butylphenyl methylpropional (UNII: T7540GJV69) hydroxycitronellal (UNII: 8SQ0VA4YUR) .alpha.-hexylcinnamaldehyde (UNII: 7X6O37OK2I) limonene, (+)- (UNII: GFD7C86Q1W) hydroxyisohexyl 3-cyclohexene carboxaldehyde (UNII: QUE43B9Z2Q) isomethyl-.alpha.-ionone (UNII: 9XP4LC555B) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide red (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:43596-0127-2 1 in 1 BOX 09/26/2018 1 NDC:43596-0127-1 9 g in 1 CONTAINER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 09/26/2018 LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 3/BEIGE
octinoxate and zinc oxide liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:43596-0128 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.075 g in 1 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 0.0784 g in 1 g Inactive Ingredients Ingredient Name Strength Dimethicone (UNII: 92RU3N3Y1O) mica (UNII: V8A1AW0880) starch, corn (UNII: O8232NY3SJ) high density polyethylene (UNII: UG00KM4WR7) silica dimethyl silylate (UNII: EU2PSP0G0W) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) carnauba wax (UNII: R12CBM0EIZ) kojic dipalmitate (UNII: 13N249RWTM) polyglyceryl-4 isostearate (UNII: 820DPX33S7) hexyl laurate (UNII: 4CG9F9W01Q) phenoxyethanol (UNII: HIE492ZZ3T) triethoxycaprylylsilane (UNII: LDC331P08E) caprylyl glycol (UNII: 00YIU5438U) chlorphenesin (UNII: I670DAL4SZ) licorice (UNII: 61ZBX54883) dimethylmethoxy chromanyl palmitate (UNII: 5G222ZDK7U) .beta.-citronellol, (R)- (UNII: P01OUT964K) butylphenyl methylpropional (UNII: T7540GJV69) hydroxycitronellal (UNII: 8SQ0VA4YUR) .alpha.-hexylcinnamaldehyde (UNII: 7X6O37OK2I) limonene, (+)- (UNII: GFD7C86Q1W) hydroxyisohexyl 3-cyclohexene carboxaldehyde (UNII: QUE43B9Z2Q) isomethyl-.alpha.-ionone (UNII: 9XP4LC555B) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide red (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:43596-0128-2 1 in 1 BOX 09/26/2018 1 NDC:43596-0128-1 9 g in 1 CONTAINER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 09/26/2018 LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 4/BEIGE
octinoxate and zinc oxide liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:43596-0129 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.075 g in 1 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 0.0784 g in 1 g Inactive Ingredients Ingredient Name Strength Dimethicone (UNII: 92RU3N3Y1O) mica (UNII: V8A1AW0880) starch, corn (UNII: O8232NY3SJ) high density polyethylene (UNII: UG00KM4WR7) silica dimethyl silylate (UNII: EU2PSP0G0W) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) carnauba wax (UNII: R12CBM0EIZ) kojic dipalmitate (UNII: 13N249RWTM) polyglyceryl-4 isostearate (UNII: 820DPX33S7) hexyl laurate (UNII: 4CG9F9W01Q) phenoxyethanol (UNII: HIE492ZZ3T) triethoxycaprylylsilane (UNII: LDC331P08E) caprylyl glycol (UNII: 00YIU5438U) chlorphenesin (UNII: I670DAL4SZ) licorice (UNII: 61ZBX54883) dimethylmethoxy chromanyl palmitate (UNII: 5G222ZDK7U) .beta.-citronellol, (R)- (UNII: P01OUT964K) butylphenyl methylpropional (UNII: T7540GJV69) hydroxycitronellal (UNII: 8SQ0VA4YUR) .alpha.-hexylcinnamaldehyde (UNII: 7X6O37OK2I) limonene, (+)- (UNII: GFD7C86Q1W) hydroxyisohexyl 3-cyclohexene carboxaldehyde (UNII: QUE43B9Z2Q) isomethyl-.alpha.-ionone (UNII: 9XP4LC555B) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide red (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:43596-0129-2 1 in 1 BOX 09/26/2018 1 NDC:43596-0129-1 9 g in 1 CONTAINER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 09/26/2018 LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 5/BEIGE
octinoxate and zinc oxide liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:43596-0130 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.075 g in 1 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 0.0784 g in 1 g Inactive Ingredients Ingredient Name Strength Dimethicone (UNII: 92RU3N3Y1O) mica (UNII: V8A1AW0880) starch, corn (UNII: O8232NY3SJ) high density polyethylene (UNII: UG00KM4WR7) silica dimethyl silylate (UNII: EU2PSP0G0W) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) carnauba wax (UNII: R12CBM0EIZ) kojic dipalmitate (UNII: 13N249RWTM) polyglyceryl-4 isostearate (UNII: 820DPX33S7) hexyl laurate (UNII: 4CG9F9W01Q) phenoxyethanol (UNII: HIE492ZZ3T) triethoxycaprylylsilane (UNII: LDC331P08E) caprylyl glycol (UNII: 00YIU5438U) chlorphenesin (UNII: I670DAL4SZ) licorice (UNII: 61ZBX54883) dimethylmethoxy chromanyl palmitate (UNII: 5G222ZDK7U) .beta.-citronellol, (R)- (UNII: P01OUT964K) butylphenyl methylpropional (UNII: T7540GJV69) hydroxycitronellal (UNII: 8SQ0VA4YUR) .alpha.-hexylcinnamaldehyde (UNII: 7X6O37OK2I) limonene, (+)- (UNII: GFD7C86Q1W) hydroxyisohexyl 3-cyclohexene carboxaldehyde (UNII: QUE43B9Z2Q) isomethyl-.alpha.-ionone (UNII: 9XP4LC555B) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide red (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:43596-0130-2 1 in 1 BOX 09/26/2018 1 NDC:43596-0130-1 9 g in 1 CONTAINER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 09/26/2018 LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 6/BEIGE
octinoxate and zinc oxide liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:43596-0131 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.075 g in 1 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 0.0784 g in 1 g Inactive Ingredients Ingredient Name Strength Dimethicone (UNII: 92RU3N3Y1O) mica (UNII: V8A1AW0880) starch, corn (UNII: O8232NY3SJ) high density polyethylene (UNII: UG00KM4WR7) silica dimethyl silylate (UNII: EU2PSP0G0W) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) carnauba wax (UNII: R12CBM0EIZ) kojic dipalmitate (UNII: 13N249RWTM) polyglyceryl-4 isostearate (UNII: 820DPX33S7) hexyl laurate (UNII: 4CG9F9W01Q) phenoxyethanol (UNII: HIE492ZZ3T) triethoxycaprylylsilane (UNII: LDC331P08E) caprylyl glycol (UNII: 00YIU5438U) chlorphenesin (UNII: I670DAL4SZ) licorice (UNII: 61ZBX54883) dimethylmethoxy chromanyl palmitate (UNII: 5G222ZDK7U) .beta.-citronellol, (R)- (UNII: P01OUT964K) butylphenyl methylpropional (UNII: T7540GJV69) hydroxycitronellal (UNII: 8SQ0VA4YUR) .alpha.-hexylcinnamaldehyde (UNII: 7X6O37OK2I) limonene, (+)- (UNII: GFD7C86Q1W) hydroxyisohexyl 3-cyclohexene carboxaldehyde (UNII: QUE43B9Z2Q) isomethyl-.alpha.-ionone (UNII: 9XP4LC555B) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide red (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:43596-0131-2 1 in 1 BOX 09/26/2018 1 NDC:43596-0131-1 9 g in 1 CONTAINER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 09/26/2018 LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 7/BEIGE
octinoxate and zinc oxide liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:43596-0132 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.075 g in 1 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 0.0784 g in 1 g Inactive Ingredients Ingredient Name Strength Dimethicone (UNII: 92RU3N3Y1O) mica (UNII: V8A1AW0880) starch, corn (UNII: O8232NY3SJ) high density polyethylene (UNII: UG00KM4WR7) silica dimethyl silylate (UNII: EU2PSP0G0W) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) carnauba wax (UNII: R12CBM0EIZ) kojic dipalmitate (UNII: 13N249RWTM) polyglyceryl-4 isostearate (UNII: 820DPX33S7) hexyl laurate (UNII: 4CG9F9W01Q) phenoxyethanol (UNII: HIE492ZZ3T) triethoxycaprylylsilane (UNII: LDC331P08E) caprylyl glycol (UNII: 00YIU5438U) chlorphenesin (UNII: I670DAL4SZ) licorice (UNII: 61ZBX54883) dimethylmethoxy chromanyl palmitate (UNII: 5G222ZDK7U) .beta.-citronellol, (R)- (UNII: P01OUT964K) butylphenyl methylpropional (UNII: T7540GJV69) hydroxycitronellal (UNII: 8SQ0VA4YUR) .alpha.-hexylcinnamaldehyde (UNII: 7X6O37OK2I) limonene, (+)- (UNII: GFD7C86Q1W) hydroxyisohexyl 3-cyclohexene carboxaldehyde (UNII: QUE43B9Z2Q) isomethyl-.alpha.-ionone (UNII: 9XP4LC555B) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide red (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:43596-0132-2 1 in 1 BOX 09/26/2018 1 NDC:43596-0132-1 9 g in 1 CONTAINER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 09/26/2018 LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 8/BEIGE
octinoxate and zinc oxide liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:43596-0133 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.075 g in 1 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 0.0784 g in 1 g Inactive Ingredients Ingredient Name Strength Dimethicone (UNII: 92RU3N3Y1O) mica (UNII: V8A1AW0880) starch, corn (UNII: O8232NY3SJ) high density polyethylene (UNII: UG00KM4WR7) silica dimethyl silylate (UNII: EU2PSP0G0W) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) carnauba wax (UNII: R12CBM0EIZ) kojic dipalmitate (UNII: 13N249RWTM) polyglyceryl-4 isostearate (UNII: 820DPX33S7) hexyl laurate (UNII: 4CG9F9W01Q) phenoxyethanol (UNII: HIE492ZZ3T) triethoxycaprylylsilane (UNII: LDC331P08E) caprylyl glycol (UNII: 00YIU5438U) chlorphenesin (UNII: I670DAL4SZ) licorice (UNII: 61ZBX54883) dimethylmethoxy chromanyl palmitate (UNII: 5G222ZDK7U) .beta.-citronellol, (R)- (UNII: P01OUT964K) butylphenyl methylpropional (UNII: T7540GJV69) hydroxycitronellal (UNII: 8SQ0VA4YUR) .alpha.-hexylcinnamaldehyde (UNII: 7X6O37OK2I) limonene, (+)- (UNII: GFD7C86Q1W) hydroxyisohexyl 3-cyclohexene carboxaldehyde (UNII: QUE43B9Z2Q) isomethyl-.alpha.-ionone (UNII: 9XP4LC555B) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide red (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:43596-0133-2 1 in 1 BOX 09/26/2018 1 NDC:43596-0133-1 9 g in 1 CONTAINER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 09/26/2018 LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 9/BROWN
octinoxate and zinc oxide liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:43596-0134 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.075 g in 1 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 0.0784 g in 1 g Inactive Ingredients Ingredient Name Strength Dimethicone (UNII: 92RU3N3Y1O) mica (UNII: V8A1AW0880) starch, corn (UNII: O8232NY3SJ) high density polyethylene (UNII: UG00KM4WR7) silica dimethyl silylate (UNII: EU2PSP0G0W) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) carnauba wax (UNII: R12CBM0EIZ) kojic dipalmitate (UNII: 13N249RWTM) polyglyceryl-4 isostearate (UNII: 820DPX33S7) hexyl laurate (UNII: 4CG9F9W01Q) phenoxyethanol (UNII: HIE492ZZ3T) triethoxycaprylylsilane (UNII: LDC331P08E) caprylyl glycol (UNII: 00YIU5438U) chlorphenesin (UNII: I670DAL4SZ) licorice (UNII: 61ZBX54883) dimethylmethoxy chromanyl palmitate (UNII: 5G222ZDK7U) .beta.-citronellol, (R)- (UNII: P01OUT964K) butylphenyl methylpropional (UNII: T7540GJV69) hydroxycitronellal (UNII: 8SQ0VA4YUR) .alpha.-hexylcinnamaldehyde (UNII: 7X6O37OK2I) limonene, (+)- (UNII: GFD7C86Q1W) hydroxyisohexyl 3-cyclohexene carboxaldehyde (UNII: QUE43B9Z2Q) isomethyl-.alpha.-ionone (UNII: 9XP4LC555B) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide red (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:43596-0134-2 1 in 1 BOX 09/26/2018 1 NDC:43596-0134-1 9 g in 1 CONTAINER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 09/26/2018 Labeler - Ventura Corporation LTD (602751344) Establishment Name Address ID/FEI Business Operations Bel Star S.A. (Colombia) 880160197 MANUFACTURE(43596-0126, 43596-0127, 43596-0128, 43596-0129, 43596-0130, 43596-0131, 43596-0132, 43596-0133, 43596-0134)